Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A bladder tumor model response to immunotherapy

J B deKernion, K P Ramming, K Fraser

    National Cancer Institute Monograph
    |December 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer's Disease.

    The journal of prevention of Alzheimer's disease·2024
    Same author

    The efficacy of toltrazuril treatment for reducing the infection intensity of Theileria orientalis Ikeda type in dairy calves.

    Veterinary parasitology·2020
    Same author

    Ventricular Flow Field Visualization During Mechanical Circulatory Support in the Assisted Isolated Beating Heart.

    Annals of biomedical engineering·2019
    Same author

    Transcutaneous electrical nerve stimulation improves fatigue performance of the treated and contralateral knee extensors.

    European journal of applied physiology·2019
    Same author

    Untargeted metabolic profiling of dogs with a suspected toxic mitochondrial myopathy using liquid chromatography-mass spectrometry.

    Toxicon : official journal of the International Society on Toxinology·2019
    Same author

    The efficacy and plasma profiles of abamectin plus levamisole combination anthelmintics administered as oral and pour-on formulations to cattle.

    Veterinary parasitology·2016
    Same journal

    Forty-five years of cancer incidence in Connecticut: 1935-79.

    National Cancer Institute monograph·1986
    Same journal

    Second cancer following cancer of the breast in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the respiratory system in Connecticut, 1935-1982.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following cancer of the digestive system in Connecticut, 1935-82.

    National Cancer Institute monograph·1985
    Same journal

    Summary: multiple primary cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    Same journal

    Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.

    National Cancer Institute monograph·1985
    See all related articles

    This study evaluated Bacillus Calmette-Guérin (BCG) and Corynebacterium parvum treatments for mouse bladder tumors. Both immunotherapies, alone or with Cytoxan, showed potential in extending survival and slowing tumor growth.

    Area of Science:

    • Immunotherapy
    • Oncology
    • Urology

    Background:

    • Bladder cancer is a significant health concern.
    • Immunotherapies like BCG are established treatments.
    • Novel treatment strategies are needed to improve outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of Bacillus Calmette-Guérin (BCG) and Corynebacterium parvum in treating transplantable mouse bladder tumors.
    • To compare the effects of BCG and C. parvum, alone and in combination with Cytoxan, on tumor growth and animal survival.

    Main Methods:

    • Treatment of mice bearing FANFT bladder tumors with BCG or C. parvum.
    • Administration of Cytoxan in conjunction with BCG or C. parvum.
    • Assessment of tumor growth retardation and increase in animal survival rates.

    Related Experiment Videos

    Main Results:

    • Both BCG and C. parvum demonstrated effectiveness in retarding tumor growth.
    • Combination therapies, particularly with Cytoxan, showed enhanced effects on survival.
    • Individual responses varied, indicating potential for tailored treatment approaches.

    Conclusions:

    • BCG and C. parvum represent viable immunotherapeutic options for bladder cancer.
    • Combination with Cytoxan may offer synergistic benefits in managing bladder tumors.
    • Further research is warranted to optimize treatment protocols and understand mechanisms of action.